On this page you'll find 10+ example sentences with Ardelyx. Discover how to use the word correctly in a sentence.
Ardelyx in a sentence
Using Ardelyx
- In the example corpus, ardelyx often appears in combinations such as: of ardelyx, ardelyx in, in ardelyx.
Context around Ardelyx
- Average sentence length in these examples: 18.6 words
- Position in the sentence: 3 start, 14 middle, 0 end
- Sentence types: 17 statements, 0 questions, 0 exclamations
Corpus analysis for Ardelyx
- In this selection, "ardelyx" usually appears in the middle of the sentence. The average example has 18.6 words, and this corpus slice is mostly made up of statements.
- Around the word, happens, zacks, won and inc stand out and add context to how "ardelyx" is used.
- Recognizable usage signals include shares of ardelyx in a and ardelyx s revenue. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "ardelyx" sits close to words such as aav, abdicating and abductor, which helps place it inside the broader word index.
Example types with ardelyx
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
According to Zacks, “Ardelyx, Inc. is a clinical-stage biopharmaceutical company. (11 words)
If that happens, Ardelyx won’t be a penny stock for long. (12 words)
Ardelyx’s revenue was down 22.2% compared to the same quarter last year. (14 words)
HC Wainwright raised their price target on Ardelyx from $9.00 to $11.00 and gave the company a “buy” rating in a research note on Wednesday, November 1st. (29 words)
Piper Sandler reissued an “overweight” rating and set a $15.00 price objective on shares of Ardelyx in a research note on Friday, May 24th. (25 words)
Jefferies Financial Group reissued a “buy” rating and issued a $11.00 price objective on shares of Ardelyx in a report on Tuesday, February 18th. (25 words)
Example sentences (17)
Finally, ProShare Advisors LLC bought a new stake in shares of Ardelyx in the 4th quarter valued at about $44,000.
HC Wainwright raised their price target on Ardelyx from $9.00 to $11.00 and gave the company a “buy” rating in a research note on Wednesday, November 1st.
IFP Advisors Inc bought a new stake in Ardelyx during the 4th quarter valued at approximately $40,000.
If that happens, Ardelyx won’t be a penny stock for long.
Prosight Management LP purchased a new position in shares of Ardelyx during the 2nd quarter worth approximately $1,276,000.
Alpha DNA Investment Management LLC lifted its holdings in shares of Ardelyx by 20.5% in the 3rd quarter.
Ardelyx’s revenue for the quarter was up 228.3% compared to the same quarter last year.
Ardelyx’s revenue was down 22.2% compared to the same quarter last year.
Finally, Barclays PLC increased its position in shares of Ardelyx by 93.5% during the third quarter.
Finally, Wedbush reiterated an “outperform” rating and set a $13.00 price target on shares of Ardelyx in a report on Friday, February 23rd.
Piper Sandler reissued an “overweight” rating and set a $15.00 price objective on shares of Ardelyx in a research note on Friday, May 24th.
ProShare Advisors LLC boosted its position in Ardelyx by 8.9% during the 1st quarter.
SJS Investment Consulting Inc. acquired a new stake in Ardelyx in the 4th quarter worth about $62,000.
Cowen assumed coverage on shares of Ardelyx in a report on Monday, February 10th.
Jefferies Financial Group reissued a “buy” rating and issued a $11.00 price objective on shares of Ardelyx in a report on Tuesday, February 18th.
According to Zacks, “Ardelyx, Inc. is a clinical-stage biopharmaceutical company.
Citadel Advisors LLC bought a new stake in Ardelyx during the 2nd quarter valued at approximately $37,000.
Common combinations with ardelyx
These word pairs occur most frequently in English texts:
- of ardelyx 8×
- ardelyx in 6×
- in ardelyx 4×
- ardelyx during 3×
- ardelyx by 3×
- ardelyx revenue 2×